JACC: CardioOncology - Prospective Evaluation of Malignancy in 17,708 Patients Randomized to Ezetimibe vs. Placebo: Analysis from IMPROVE-IT
Episode Description
Commentary by Dr. Kathryn Ruddy
We use cookies to run this site. Analytics cookies, which show us how it's used, stay off unless you accept them. Change your mind any time with the cookie button at the bottom right. How we use cookies